Moore Capital Management’s Medtronic MDT Stock Holding History

Moore Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-210,572	Closed	-$26.4M	–	813
2021 Q3	$26.4M	Sell	210,572 -14,730	-7%	-$1.91M	0.4%	55
2021 Q2	$28M	Buy	+225,302	New	+$28.3M	0.4%	52
2017 Q2	–	Sell	-25,000	Closed	-$2.01M	–	221
2017 Q1	$2.01M	Buy	+25,000	New	+$1.95M	0.05%	150
2016 Q1	–	Sell	-375,000	Closed	-$28.2M	–	303
2015 Q4	$28.8M	Buy	+375,000	New	+$28.2M	0.89%	26
2015 Q2	–	Sell	-25,233	Closed	-$1.97M	–	477
2015 Q1	$1.97M	Buy	+25,233	New	+$1.91M	0.04%	283

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Moore Capital Management's MDT Position: Q4 2021 in Review

Moore Capital Management sold out of Medtronic (MDT) in Q4 2021, closing a stake of 210,572 shares — an estimated $26.4M sold.

Moore Capital Management first reported a position in MDT in Q1 2015 and held it in 5 quarters. The position peaked at $28.8M in Q4 2015. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

Moore Capital Management reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
Moore Capital Management sold 210,572 Medtronic shares in Q4 2021, an estimated $26.4M.
Moore Capital Management first reported a position in Medtronic in Q1 2015 and held it in 5 quarters.
Moore Capital Management's Medtronic position peaked at $28.8M in Q4 2015.
2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Moore Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.